Cannabinoids for postoperative analgesia?
To the Editor: We read with interest the article on the effects of nabilone on postoperative pain by Pierre Beaulieu. 1 While it is unfortunate that his results did not generate firm conclusions, we believe that descriptive subgroup analyses may have yielded some important information regarding the effects of nabilone on postoperative morphine consumption and side-effects. Nineteen of the 41 patients in the study underwent hysterectomy or myomectomy, which is a surgically homogenous patient population for whom it would have been interesting to have compared the effects of placebo, ketoprofen and nabilone doses of 1 and 2 mg on morphine consumption, visual analogue scale (VAS) scores and secondary outcomes. Eighteen of the 41 patients underwent orthopedic surgery (hip or knee arthroplasty), which represents a different surgical population of potentially greater heterogeneity, with an additional confounding factor that knee arthroplasties are associated with more postoperative pain compared with hip arthroplasty. 2 A greater number of knee arthroplasty patients in the nabilone 2 mg group could explain why there is an apparent possible hyperalgesic effect of nabilone. Hence, it would be interesting to know the breakdown of knee/hip arthroplasty by study group (placebo, ketoprofen and nabilone 1 and 2 mg), and the results (morphine consumption, VAS scores and secondary outcomes) according to the orthopedic procedure and study group. 1 with great interest. Although angioedema can cause rapid, progressive airway compromise, facial and oral cavity edema as a complication of angiotensin converting enzyme inhibitors (ACEIs) therapy is under-recognized, as described in the review article.
Reply
1 A potential role of angiotensin receptor blocking (ARB) drugs should also be considered.
Recently, we experienced two cases strongly suspected of being secondary to angioedema, following cardiopulmonary bypass (CPB) surgery. Both patients had obvious tongue swelling immediately after their operations (Figure, upper panels) . We initially suspected impaired venous return or traumatic sequelae resulting from the endotracheal tube or bite block as potential etiologies. However, the tongues of both patients were pink-coloured, without evidence of venous congestion, thus making an obstructive circulatory disturbance unlikely. Eyelid edema was not observed, and fluid balance and serum protein and albumin concentrations were within normal ranges. Heart failure and increases in central venous pressure were also excluded as possible causes in the setting of pulmonary catheter measurements that were within accepted physiological ranges.
On further review, it was identified that the first patient was being treated for hypertension with candesartan, an ARB drug, and the second patient had been receiving long-term therapy with enalapril, an ACEI. As with all ACEIs, enalapril potentiates the effects and augments the survival of bradykinin in humans. 2 Preoperative ACEIs augment the kinin response to CPB 3 and increased serum bradykinin levels have been reported in association with CPB. 4 Theoretically, ARBs do not increase bradykinin levels and the complication might not be induced by ARBs. However, angioedema associated with ARBs in a patient who had experienced angioedema secondary to ACEIs has been described. 5 Patients receiving not only ACEIs but also ARBs 6 might be susceptible to angioedema, and CPB could present a precipitating factor. Other triggering factors, such as recent airway intervention, trauma, or exposure to irritant fumes have also been discussed. 1 We suggest that cardiac surgery with CPB might present an additional risk factor for angioedema in patients receiving ACEIs, ARBs, or a combination of these two drugs.
Although tongue swelling disappeared within a few hours in both patients with conservative management (Figure, lower panels) , we monitored them carefully for several days to ensure airway patency. Considering the increasingly common use of ACEIs and ARBs for the treatment of hypertension and heart failure, anesthesiologists should consider these drug-related factors as a potential cause of angioedema in the perioperative setting, especially for cardiac surgery patients. 
